Healthcare & Life Sciences
SwanBio Therapeutics
United Statesswanbiotx.com/
SwanBio Therapeutics is a startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About SwanBio Therapeutics
Based in the United States, SwanBio Therapeutics is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
A gene therapy company advancing AAV-based therapies for inherited neurological conditions, with a lead program targeting Adrenomyeloneuropathy (AMN).
Explore SwanBio Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.